Max Robotics — Global Service Robot Directory + US Certification

About

Selma Masic is a urological surgeon and researcher whose work sits at the cutting edge of minimally invasive and robotic techniques in kidney cancer management. Her research focuses primarily on robotic surgery for renal cell carcinoma (RCC), nephron-sparing approaches, and the optimization of diagnostic strategies for renal masses. Masic has made notable contributions to one of urology's most technically demanding procedures — robotic nephrectomy with inferior vena cava thrombectomy — exploring its feasibility, evolving techniques, and clinical outcomes in a field historically dominated by open surgery. Her 2021 paper on this topic has already garnered 12 citations, reflecting strong interest from the surgical community. She has also advanced the conversation around renal mass biopsy as a cost-effective, lower-morbidity strategy for managing localized renal masses, and has contributed meaningfully to debates surrounding retroperitoneal robotic partial nephrectomy, helping define the future trajectory of nephron-sparing surgery. Across her body of work, Masic demonstrates a consistent commitment to refining surgical approaches that balance oncological efficacy with patient safety, making her an emerging voice in academic urology worthy of close attention by surgeons and trainees alike.